Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperhomocysteinemia: no longer a consideration in the management of venous thromboembolism.

Current opinion in pulmonary medicine - 1 Sept 2008

Ray Joel G

Abstract excerpt

PURPOSE OF REVIEW: To determine whether clinicians should continue to screen for or treat hyperhomocysteinemia among individuals with venous thromboembolism. RECENT FINDINGS: The present review addresses four questions: Is hyperhomocysteinemia a risk factor for venous thromboembolism? Are the genetic polymorphisms that cause hyperhomocysteinemia risk factors for venous thromboembolism? Does lowering plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Homocysteine
Share to Hyperhomocysteinemia

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mass Screening

Share to Polymorphism, Genetic

Share to Risk Factors

Share to Venous Thromboembolism

Source

Identifiers

PMID: 18664964
DOI: 10.1097/MCP.0b013e328307ee38

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hyperhomocysteinemia: no longer a consideration in the management of venous thromboembolism.PMID 18664964Read ↗

Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study.Semantic proximity Read ↗

Hyperhomocysteinemia as a risk factor for venous thrombosis.Semantic proximity Read ↗

[Effect of hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C --> T mutation in venous thromboembolism risk of young adults].Semantic proximity Read ↗

Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.Semantic proximity Read ↗

Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.Semantic proximity Read ↗

MTHFR A1298C and C677T Polymorphisms Are Associated with Increased Risk of Venous Thromboembolism: A Retrospective Chart Review Study.Semantic proximity Read ↗

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.Semantic proximity Read ↗

Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.Semantic proximity Read ↗

No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.Semantic proximity Read ↗

Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.Semantic proximity Read ↗

Hereditary thrombophilia and venous thromboembolism.Semantic proximity Read ↗

Role of polymorphisms in factor V (FV Leiden), prothrombin, plasminogen activator inhibitor type-1 (PAI-1), methylenetetrahydrofolate reductase (MTHFR) and cystathionine β-synthase (CBS) genes as risk factors for thrombophilias.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.